DozoFLEX
Commercial- Indications
- Osteoarthritis
Company intelligence / Profile preview
Dozo Pharma Private Limited, operating under the flagship of Dr Dozo Laboratories since 1996, focuses on pharmaceutical research with marketed products targeting osteoarthritis pain relief and diabetes management. The company claims innovation in developing novel compounds for major diseases but does not disclose detailed clinical results or regulatory status for its products. Its offerings appear to be commercially available nutraceuticals or supplements rather than approved pharmaceuticals.[3][6][7]
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dozo Pharma Private Limited.